0001958244-23-000852.txt : 20230608 0001958244-23-000852.hdr.sgml : 20230608 20230608175131 ACCESSION NUMBER: 0001958244-23-000852 CONFORMED SUBMISSION TYPE: 144 PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20230608 DATE AS OF CHANGE: 20230608 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: FIBROGEN INC CENTRAL INDEX KEY: 0000921299 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 144 SEC ACT: 1933 Act SEC FILE NUMBER: 001-36740 FILM NUMBER: 231003179 BUSINESS ADDRESS: STREET 1: 409 ILLINOIS STREET CITY: SAN FRANCISCO STATE: CA ZIP: 94158 BUSINESS PHONE: 415-978-1200 MAIL ADDRESS: STREET 1: 409 ILLINOIS STREET CITY: SAN FRANCISCO STATE: CA ZIP: 94158 REPORTING-OWNER: COMPANY DATA: COMPANY CONFORMED NAME: Ho Maykin CENTRAL INDEX KEY: 0001646395 FILING VALUES: FORM TYPE: 144 MAIL ADDRESS: STREET 1: C/O AGIOS PHARMACEUTICALS, INC. STREET 2: 88 SIDNEY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 144 1 primary_doc.xml 144 0001646395 XXXXXXXX LIVE 0000921299 FibroGen, Inc. 001-36740 409 Illinois Street San Francisco CA 94158 1-415-978-1200 May-Kin Ho Director Common Goldman Sachs & Co. LLC 200 West Street New York NY 10282 8520 151485.6 97582416 06/08/2023 NASD Common 06/07/2023 Acquired as compensation -- Restricted Stock Units FGEN N 8520 06/07/2023 Compensation Y The sales of shares set forth herein are made in connection with a selling plan dated 3/3/2023, that is intended to comply with Rule 10b5-1(c). 06/08/2023 03/03/2023 Goldman Sachs & Co. LLC on behalf of May-Kin Ho